Literature DB >> 24988136

New recommendations in prostate cancer screening and treatment.

Lisa K Adams1, Lindsay S Ferrington.   

Abstract

Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.

Entities:  

Mesh:

Year:  2014        PMID: 24988136     DOI: 10.1097/01.JAA.0000451872.86566.bf

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  2 in total

Review 1.  Do African-American men need separate prostate cancer screening guidelines?

Authors:  Divya Shenoy; Satyaseelan Packianathan; Allen M Chen; Srinivasan Vijayakumar
Journal:  BMC Urol       Date:  2016-05-10       Impact factor: 2.264

2.  FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.

Authors:  Libin Ma; Huadong He; Kang Jiang; Peiwu Jiang; Han He; Shengjia Feng; Kean Chen; Jia Shao; Gang Deng
Journal:  Aging (Albany NY)       Date:  2020-04-13       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.